Related Experiment Video
Updated: Feb 18, 2026
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
US National Cancer Institute-China Collaborative Studies on Chinese Medicine and Cancer
Libin Jia1, Hongsheng Lin1, Joost Oppenheim1
1Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China.
Collaborations between the US National Cancer Institute (NCI) and Chinese institutions have advanced the study of Chinese medicine (CM) for cancer prevention and treatment, focusing on botanical drugs. This research has led to the formation of the International Consortium for CM and Cancer.
Area of Science:
- Integrative Oncology
- Pharmacology
- Traditional Chinese Medicine
Background:
- Began in 2007, collaborations between the US National Cancer Institute (NCI) Office of Cancer Complementary and Alternative Medicine (OCCAM) and Chinese research institutes.
- Focus on Chinese medicine (CM) and cancer research, including CM drugs and compounds studied at NCI labs.
Discussion:
- Exploration of cancer prevention strategies using CM.
- Investigation into the mechanisms of action for botanical drugs.
- Analysis and quality control (QC) of CM components.
Key Insights:
- Summarizes discoveries and progress in CM cancer research.
- Highlights anticancer activity screening of CM compounds.
- Facilitated by jointly convened workshops.
Outlook:
- Established the International Consortium for CM and Cancer.
- Aims to promote international collaborations in CM and cancer research.
- Fosters further research into botanical drugs for cancer therapy.
